Li Zhou
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Gout, Hyperuricemia, Uric Acid
- Biochemistry top 5%
- Sulfur Compounds in Biology
Papers in
-
- Inflammasome and immune disorders 6
- Cell death mechanisms and regulation 6
- Nephrology 16
- Chronic Kidney Disease and Diabetes 8
- Renal Diseases and Glomerulopathies 6
- Acute Kidney Injury Research 6
- Co-authors
- Limin Lü (30 shared papers)Hong Xue (19 shared papers)Letian Shan (33 shared papers)Yang Shen (12 shared papers)Hongyan Xie (11 shared papers)Naijun Miao (11 shared papers)Yü Huang (10 shared papers)Qian Cheng (7 shared papers)
- Journals
- Acta Pharmacologica Sinica (15 papers)Frontiers in Pharmacology (8 papers)Drug Design Development and Therapy (4 papers)PLoS ONE (3 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Li Zhou
115 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 119
- Nephrology 312
- Biochemistry 141
- Pathology and Forensic Medicine 289
- Molecular Biology 1.2k
- Cancer Research 190
Countries citing papers authored by Li Zhou
This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).
Fields of papers citing papers by Li Zhou
This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 192 | |
| 2 | 2020 | 152 | |
| 3 | 2017 | 140 | |
| 4 | 2017 | 137 | |
| 5 | 2011 | 91 | |
| 6 | 2013 | 67 | |
| 7 | 2020 | 61 | |
| 8 | 2022 | 59 | |
| 9 | 2010 | 55 | |
| 10 | 2017 | 54 | |
| 11 | 2014 | 51 | |
| 12 | 2016 | 50 | |
| 13 | 2018 | 48 | |
| 14 | 2017 | 47 | |
| 15 | 2019 | 47 | |
| 16 | 2016 | 43 | |
| 17 | 2020 | 40 | |
| 18 | 2021 | 39 | |
| 19 | 2014 | 38 | |
| 20 | 2018 | 38 |
About Li Zhou
Li Zhou is a scholar working on Molecular Biology, Nephrology, Pathology and Forensic Medicine, Rheumatology and Epidemiology, having authored 119 papers that have together received 2.8k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (10 papers), Tea Polyphenols and Effects (8 papers), Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (6 papers), Renin-Angiotensin System Studies (6 papers), Inflammasome and immune disorders (6 papers), Acute Kidney Injury Research (6 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Nephrology (312 citations), Biochemistry (141 citations), Pathology and Forensic Medicine (289 citations), Molecular Biology (1.2k citations) and Cancer Research (190 citations). Li Zhou has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Limin Lü, Hong Xue, Letian Shan, Yang Shen, Hongyan Xie, Naijun Miao, Yü Huang, Qian Cheng, Zhuanli Zhou and Jun Ni. Their work appears in journals such as Acta Pharmacologica Sinica, Frontiers in Pharmacology, Drug Design Development and Therapy, PLoS ONE and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.